Chemoinformaics analysis of 3-METHOXY-2-METHYLBENZO[B][1]BENZOXEPINE-1,7-DIOL
| Molecular Weight | 270.284 | nRot | 1 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 25 |
| Exact Molecular Weight | 270.089 | nRing | 3 |
| Solubility: LogS | -5.694 | nHRing | 1 |
| Solubility: LogP | 4.771 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 39.2631 |
| nHD | 2 | BPOL | 17.5169 |
| QED | 0.505 |
| Synth | 5.761 |
| Natural Product Likeliness | 3.472 |
| NR-PPAR-gamma | 0.065 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.973 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -5.088 |
| MDCK | 0.000024 |
| BBB | 0.419 |
| PPB | 0.925776 |
| VDSS | 2.502 |
| FU | 0.0832169 |
| CYP1A2-inh | 0.024 |
| CYP1A2-sub | 0.91 |
| CYP2c19-inh | 0.225 |
| CYP2c19-sub | 0.928 |
| CYP2c9-inh | 0.416 |
| CYP2c9-sub | 0.043 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.5 |
| CYP3a4-inh | 0.455 |
| CYP3a4-sub | 0.279 |
| CL | 15.727 |
| T12 | 0.024 |
| hERG | 0.005 |
| Ames | 0.528 |
| ROA | 0.966 |
| SkinSen | 0.523 |
| Carcinogencity | 0.74 |
| EI | 0.85 |
| Respiratory | 0.98 |
| NR-Aromatase | 0.928 |
| Antiviral | Yes |
| Prediction | 0.798423 |